| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/22/2004 | WO2003052082A3 Fusion partner cells and uses thereof |
| 04/22/2004 | WO2003046506A3 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies |
| 04/22/2004 | WO2003040345A3 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/22/2004 | WO2003027248A8 Antibody inhibitors of gdf-8 and uses thereof |
| 04/22/2004 | WO2003022202A9 Compositions and methods for treatment of cancer |
| 04/22/2004 | WO2003020763A9 Soluble t cell receptor |
| 04/22/2004 | WO2003004659A8 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 04/22/2004 | WO2002102846A3 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 04/22/2004 | WO2002092782A3 Diagnosis and treatment of malignant neoplasms |
| 04/22/2004 | WO2002092017A8 Human antipneumococcal antibodies from non-human animals |
| 04/22/2004 | WO2002090567A3 Sperm-specific cation channel, and uses therefor |
| 04/22/2004 | WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/22/2004 | WO2002062970A8 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 04/22/2004 | WO1991007986A8 Method of treating septic shock |
| 04/22/2004 | US20040078849 Modulating developmental transitions in plants |
| 04/22/2004 | US20040078848 Expression of trehalose 6-phosphate synthase and trehalose 6-phosphate phosphatase in plant[[s]] plastids |
| 04/22/2004 | US20040078842 Protein with endo-chitinase activity |
| 04/22/2004 | US20040078835 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 04/22/2004 | US20040078833 Mutations in and genomic structure of herg - along QT syndrome gene |
| 04/22/2004 | US20040078076 Purified submucosa graft material |
| 04/22/2004 | US20040077985 Method of replenishing cells damaged by treatment for cancer |
| 04/22/2004 | US20040077842 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 04/22/2004 | US20040077840 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroups B epitopes |
| 04/22/2004 | US20040077837 Microtubule-associated proteins and tubulins |
| 04/22/2004 | US20040077828 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 04/22/2004 | US20040077613 Stimulation of preadipocyte differentiation; insulin resis-tance syndrome, dyslipidemia, type 2 diabetes; LXR alpha receptor agonists |
| 04/22/2004 | US20040077577 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes |
| 04/22/2004 | US20040077552 Inflammation-inhibiting compounds |
| 04/22/2004 | US20040077538 Activates patients own factor VII to VIIa; limits thrombin formation |
| 04/22/2004 | US20040077536 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 04/22/2004 | US20040077086 Animal protein free media for cultivation of cells |
| 04/22/2004 | US20040077085 Antisense modulation of CDC14A expression |
| 04/22/2004 | US20040077084 Antisense modulation of histone deacetylase 4 expression |
| 04/22/2004 | US20040077082 Oligonucleotides with 5'- and 3'-terminal hairpins that may be configured to regulate the expression of a gene |
| 04/22/2004 | US20040077079 Methods, kits and production plant for use in the production of cell colony forming units from a mammalian tissue explant and to the use of cells from such cell colony forming units in treatment of mammals suffering from tissue disorders |
| 04/22/2004 | US20040077066 Purified active HCV NS2/3 protease |
| 04/22/2004 | US20040077064 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 04/22/2004 | US20040077053 Methods to identify growth differentiation factor (GDF) receptors |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040077049 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 04/22/2004 | US20040077046 Histone deacetylase-related gene and protein |
| 04/22/2004 | US20040077045 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA) |
| 04/22/2004 | US20040077043 Novel dendritic cell wall membrane and use thereof |
| 04/22/2004 | US20040077042 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 04/22/2004 | US20040077029 Human protooncogene and protein encoded therein |
| 04/22/2004 | US20040077021 Haptens, intermediates, and immunogens that are useful in the production of antibodies specific for the methylenedioxy class of amphetamine derivatives |
| 04/22/2004 | US20040077016 The bacteria are good research materials for investigating the interrelation between enzyme structures and functions since they are stable at extreme pH, crystallize easily and are easy- to-handle |
| 04/22/2004 | US20040077013 DNA constructs, host cells and production methods for the expression and recovery of polypeptides altered to have glycosylation sites added or deleted; employ a DNA segment corresponding to a mammalian tissue plasminogen activator |
| 04/22/2004 | US20040077009 Human cyclin-dependent kinase (hPNQALRE) |
| 04/22/2004 | US20040077007 Human SMN-like protein |
| 04/22/2004 | US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein |
| 04/22/2004 | US20040076955 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/22/2004 | US20040076951 Also antibodies, gene chips, transgenic non-human animals |
| 04/22/2004 | US20040076945 Compositions comprising reproductive cell media and methods for using such compositions |
| 04/22/2004 | US20040076657 Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced |
| 04/22/2004 | US20040076646 Stimulating the immune system of a host to mount an attack on tumor cells and/or antigens |
| 04/22/2004 | US20040076635 Genetic vaccine, polypeptide encoded by a nucleotide sequence genome, a vector, a transgenic cell, for preventing and treating viral infections |
| 04/22/2004 | US20040076631 Treating infections caused by respiratory syncytial virus, transfected eukaryotic cells, isolating human B cells from transfected mouse, use for immunoassay, diagnosis the virus, test kits |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076625 A fusion proteins comprising self or non-self antigens, is used for treatment and prevention of immunoglobulin E related diseases, gene expression |
| 04/22/2004 | US20040076622 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| 04/22/2004 | US20040076620 Removing blood cells from mammal, expanding blood cells with stem cell factor, at least seven times in less than seven days, maintaining three-dimensional geometry, purification, detoxification, reintroducing the cells back into mammal |
| 04/22/2004 | US20040076619 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 04/22/2004 | US20040076617 Culturing the progenitor cells with stromal cells in vitro, a medium comprising at least one interleukin-6 (IL-6) family cytokine; using for gene targeting, and therapeutic purposes |
| 04/22/2004 | US20040076612 For drug screening hepatitis C virus drugs |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/22/2004 | US20040076604 Tolergenic antigen presenting cells and in treating immune-inflammatory conditions |
| 04/22/2004 | US20040076603 Using copper chelate; for use in/ex vivo |
| 04/22/2004 | DE10296800T5 Inhibitoren von Isoformen der DNA Methyltransferase Inhibitors of DNA methyltransferase isoforms of |
| 04/22/2004 | DE10136702B4 System zur zell- und entwicklungsspezifischen Selektion differenzierender embryonaler Stammzellen, adulter Stammzellen und embryonaler Keimbahnzellen System for cell and developmental selection differentiating embryonic stem cells, adult stem cells and embryonic germ cells |
| 04/22/2004 | CA2501949A1 Implantation of encapsulated biological materials for treating diseases |
| 04/22/2004 | CA2501630A1 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | CA2501289A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | CA2501226A1 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
| 04/22/2004 | CA2500772A1 Uses of human zven antagonists |
| 04/21/2004 | WO2004035768A1 Antigen transduced t cells used as a delivery system for antigens |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1411115A1 Cell culture composition comprising polyethylene glycol |
| 04/21/2004 | EP1411064A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 04/21/2004 | EP1411061A1 Poly-alpha2,8-sialic acid mimetic peptides and their application |
| 04/21/2004 | EP1410801A1 Method for promoting hematopoietic cell proliferation and differentiation |
| 04/21/2004 | EP1410304A2 Method for epigenetic feature selection |
| 04/21/2004 | EP1410038A2 Assays for identifying modulators of rhomboid polypeptides |
| 04/21/2004 | EP1410019A1 Cardiovascular safety assay |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409748A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 04/21/2004 | EP1409737A2 Methods for detecting and treating the early onset of aging-related conditions |
| 04/21/2004 | EP1409718A2 Canine toxicity genes |
| 04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 04/21/2004 | EP1409713A1 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409699A1 Recombinant vectors derived from adeno-associated virus expressing tam67 for gene therapy |
| 04/21/2004 | EP1409698A2 Ires enabled gene trapping in plants |
| 04/21/2004 | EP1409694A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 04/21/2004 | EP1409688A2 Nucleic acid sequences encoding enantioselective amidases |
| 04/21/2004 | EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 04/21/2004 | EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF |
| 04/21/2004 | EP1409682A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |